1. Home
  2. Browse
  3. Psychiatry
  4. Resources

Resources

121 - 135 of 139 Results
Sort Results:
Commentary: Safety of Using ADHD Stimulant Meds with Decongestants April 2011
Guideline: Canadian ADHD Practice Guidelines (2011) March 2011
Commentary: Invega Sustenna (Paliperidone Prolonged-Release Injection) October 2010
Commentary: Canadian Depression Guidelines: Overview of Pharmacotherapy June 2010
Guideline: Depression and Coronary Disease: Screening, Referral, and Treatment February 2010
Commentary: Antidepressants and Cardiovascular Risk February 2010
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) February 2010
Guideline: Sleep Apnea and Cardiovascular Disease (2008) October 2008
Guideline: Diagnosis and Treatment of Sleep Disordered Breathing in Adults (2006) October 2008
Guideline: Diagnosis and Treatment of Sleep Apnea 2008 Update (Canadian) October 2008
Guideline: American Heart Association Scientific Statement: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving ADHD Medications: Correction June 2008
Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: American Heart Association Scientific Statement: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving ADHD Medications. June 2008
Patient Education: New Information Concerning Your Child’s ADHD Medication June 2008